April 14, 2021 – After reports of rare blood clotting, the U.S., EU and South Africa have paused the rollout of Johnson & Johnson’s coronavirus vaccine. The move follows similar cases after doses of AstraZeneca’s vaccine.
April 14, 2021 – After reports of rare blood clotting, the U.S., EU and South Africa have paused the rollout of Johnson & Johnson’s coronavirus vaccine. The move follows similar cases after doses of AstraZeneca’s vaccine.